文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

接受静脉-静脉体外膜氧合成人中的限制性输血实践:单中心经验

Restrictive Transfusion Practice in Adults Receiving Venovenous Extracorporeal Membrane Oxygenation: A Single-Center Experience.
PubMed 文献 · Crit Care Explor · 2020-01-29
一句话结论单中心回顾性研究提示,静脉-静脉体外膜氧合期间采用限制性输血策略(目标血红蛋白>80 g/L)与宽松策略(>100 g/L)生存结局相似,且每例节省454英镑。

该单中心回顾性观察研究纳入2011至2017年接受静脉-静脉体外膜氧合超过24小时的402例成人患者,比较宽松输血策略(2011-2014年,目标血红蛋白>100 g/L,99例)与限制性输血策略(2014-2017年,目标血红蛋白>80 g/L,303例)的生存结局、输血相关不良事件和成本。结果显示限制性策略实施后生存结局未改变,体外血流速降低0.5 L/min,限制性策略下未存活者红细胞用量更高,每例节省454英镑。作者认为静脉-静脉体外膜氧合期间采用更限制性的红细胞输血策略更具成本效益,且与宽松策略相比生存结局相似。

要点

  • 单中心回顾性研究纳入402例静脉-静脉体外膜氧合成人患者,限制性策略组303例(目标血红蛋白>80 g/L),宽松策略组99例(目标血红蛋白>100 g/L)。
  • 限制性输血策略实施后生存结局未改变。
  • 限制性输血策略下体外血流速降低0.5 L/min。
  • 限制性策略下静脉-静脉体外膜氧合未存活者红细胞用量更高。
  • 限制性策略每例节省454英镑。

适用人群与场景

  • 年龄16岁及以上、接受静脉-静脉体外膜氧合超过24小时的成人患者,2011至2017年单中心高容量三级重症监护病房。

诊断标准与关键阈值

  • 宽松输血策略(2011-2014年)目标血红蛋白水平大于100 g/L。
  • 限制性输血策略(2014-2017年)目标血红蛋白水平大于80 g/L。

研究设计与关键结果

  • 研究类型为回顾性观察研究,单中心,纳入402例接受静脉-静脉体外膜氧合超过24小时的成人患者,其中宽松输血策略组99例(2011-2014年,目标血红蛋白>100 g/L),限制性输血策略组303例(2014-2017年,目标血红蛋白>80 g/L)。
  • 限制性输血策略实施后生存结局未改变。
  • 限制性输血策略下体外血流速降低0.5 L/min。
  • 限制性策略下静脉-静脉体外膜氧合未存活者红细胞用量更高。
  • 限制性策略每例节省454英镑。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,静脉-静脉体外膜氧合期间采用更限制性的红细胞输血策略(目标血红蛋白>80 g/L)更具成本效益,且与宽松策略(目标血红蛋白>100 g/L)相比生存结局相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Restrictive transfusion policies have been adopted in critical care, although these have not included patients receiving extracorporeal membrane oxygenation. We aimed to assess survival outcomes, adverse events related to RBC transfusion, and cost implications following a change from a "liberal" to a "restrictive" RBC transfusion practice in patients receiving extracorporeal membrane oxygenation.

DESIGN: Retrospective observational study.

SETTING: Single high-volume tertiary critical care department at a university hospital.

PATIENTS: Patients 16 years old or greater receiving venovenous extracorporeal membrane oxygenation between 2011 and 2017 for more than 24 hours.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Clinical diagnoses, complications, outcomes, median hemoglobin, and hematocrit levels were obtained from patients' electronic records. All laboratory results for hemoglobin and hematocrit were included. RBC transfusions were obtained from prescription charts. We included 402 patients: 99 during a "liberal" transfusion practice (2011-2014)-when the target hemoglobin level was greater than 100 g/L; and 303 treated during a "restrictive" transfusion practice (2014-2017) when the target hemoglobin level was greater than 80 g/L. We found that survival outcomes did not change following the implementation of a "restrictive" transfusion policy. There was also a decrease in the extracorporeal blood flow rates with restrictive transfusion of 0.5 L/min. Nonsurvivors of venovenous extracorporeal membrane oxygenation had higher usage of RBC units following a change in transfusion practice. The restrictive strategy allowed a cost saving of £454 per patient.

CONCLUSIONS: These results suggest that the adoption of a more restrictive approach to RBC transfusion during venovenous extracorporeal membrane oxygenation is more cost-effective and associated with similar survival outcomes, than when compared with a more liberal approach.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Doyle AJ, Richardson C, Sanderson B, et al. Restrictive Transfusion Practice in Adults Receiving Venovenous Extracorporeal Membrane Oxygenation: A Single-Center Experience. Crit Care Explor. 2020. PMID: 32166297. doi:10.1097/CCE.0000000000000077

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。